TIDMNXKE
RNS Number : 0802N
Nomura Nikkei 225 Eur Hdg UCITS
26 January 2016
Circular to Shareholders in
NOMURA NEXT FUNDS IRELAND PUBLIC LIMITED COMPANY
an open-ended investment company with variable capital and an
umbrella fund with segregated liability between sub-funds
established under the laws of Ireland
26 January 2016
This Circular is being sent to you as a Shareholder in Nomura
NEXT FUNDS Ireland plc (the "Company"). This document is important
and requires your immediate attention. If you are in any doubt as
to the action you should take you should seek advice from your
independent financial adviser immediately.
Capitalised terms used herein, unless otherwise defined shall
have the same meaning as given to them in the Prospectus of the
Company.
If you have sold or transferred all of your Shares in the Fund
please hand this document at once to the stockbroker, bank or other
agent through whom the sale or transfer was effected, for
transmission to the purchaser or transferee as soon as
possible.
This Circular is not required to be and has not been reviewed by
the Central Bank of Ireland.
The Directors of the Company consider that the proposed
amendments to the Supplement of the Fund detailed in the attached
are in the best interests of Shareholders of the Fund.
Nomura NEXT FUNDS Ireland Plc
Beaux Lane House
Mercer Street Lower
Dublin 2
Ireland
26 January 2016
Dear Shareholder,
Nomura Nikkei 225 EUR-Hedged UCITS ETF
Nomura Nikkei 225 USD-Hedged UCITS ETF
Nomura JPX-Nikkei 400 Net Total Return Daily EUR Hedged Index
UCITS ETF
Nomura JPX-Nikkei 400 Net Total Return Daily USD Hedged Index
UCITS ETF
(each a "Fund" and together the "Funds")
We are writing to you as a Shareholder of the Funds. The purpose
of this letter is to notify you of certain actions which are being
or are proposed to be taken with respect to the Fund namely:
1 Changes to the Supplement for the Fund
The Investment Manager has advised the Directors of the Company
that is intended to register the Funds for sale in Switzerland.
However, in order for the Funds to be registered for sale in
Switzerland, the prior approval of the Swiss Financial Market
Supervisory Authority ("FINMA") must be obtained. As each of the
Supplements for the Funds currently provides for the use of funded
swaps as part of the "Secondary Investment Strategy" of each Fund
FINMA will not permit the registration of the Funds for sale in
Switzerland.
The Directors of the Company (after consultation and validation
with the Investment Manager and the Sub-Investment Manager) propose
to make changes to the Supplements for the Funds to delete
reference to the use of funded swaps under the "Secondary
Investment Strategy" section.
All changes are reflected in a new Supplement for each Fund
which are set out in the following Appendices:-
-- Appendix 1 - Nomura Nikkei 225 EUR-Hedged UCITS ETF Supplement;
-- Appendix 2 - Nomura Nikkei 225 USD-Hedged UCITS ETF Supplement;
-- Appendix 3 - Nomura JPX-Nikkei 400 Net Total Return Daily EUR
Hedged Index UCITS ETF Supplement; and
-- Appendix 4 - Nomura JPX-Nikkei 400 Net Total Return Daily USD
Hedged Index UCITS ETF Supplement.
Each of the Supplements for the Funds will be available free of
charge to Shareholders following the prior approval of and/or
notification to the relevant regulatory authorities and, in
particular, the Central Bank
2 Documents available for Inspection
Shareholders may obtain the Prospectus, the Supplement, the
latest annual and semi-annual reports and copies of the Memorandum
and Articles of Association free of charge from the registered
office of the Company.
3 Conclusion
The Directors of the Company accept responsibility for the
information contained in this Circular.
The proposed changes described above are subject to the prior
approval of and/or notification to the relevant regulatory
authorities and, in particular, the Central Bank. It is expected
that the change will be effective as and from 10 February 2016 or
such earlier or later date as the Directors may determine following
receipt of all necessary approvals to the change.
Should you wish to redeem or exchange your Shares in the Fund
you may do so in the manner prescribed in the Prospectus.
Yours faithfully,
_____________
For and on behalf of
Nomura NEXT FUNDS Ireland plc
Appendix 1
Nomura Nikkei 225 EUR-Hedged UCITS ETF
Supplement to the Prospectus
This Supplement contains information in relation to the Nomura
Nikkei 225 EUR-Hedged UCITS ETF (the "Fund"), a sub-fund of Nomura
NEXT FUNDS Ireland plc (the "Company") an umbrella type open-ended
investment company with variable capital, governed by the laws of
Ireland and authorised by the Central Bank of Ireland (the "Central
Bank") of Block D, Iveagh Court, Harcourt Road, Dublin 2,
Ireland.
This Supplement forms part of, and must be read in conjunction
with, the Prospectus of the Company dated 23 December 2014, as may
be amended, supplemented or modified from time to time, (the
"Prospectus") and may not be distributed unless accompanied by the
Prospectus (other than to prior recipients of the Prospectus).
THIS DOCUMENT IS IMPORTANT. BEFORE YOU PURCHASE ANY OF THE
SHARES REPRESENTING INTERESTS IN THE FUND DESCRIBED IN THIS
SUPPLEMENT YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE NATURE
OF SUCH AN INVESTMENT, THE RISKS INVOLVED AND YOUR OWN PERSONAL
CIRCUMSTANCES. IF YOU ARE IN ANY DOUBT ABOUT THE CONTENTS OF THIS
SUPPLEMENT YOU SHOULD TAKE ADVICE FROM AN APPROPRIATELY QUALIFIED
ADVISOR.
Capitalised terms used in this Supplement will have the meanings
given to them in the Definitions section below or in the
Prospectus.
In addition to investing in equities and equity related
securities, transferable securities and other eligible assets, it
is the intention of the Company to invest on behalf of the Fund in
financial derivative instruments ("FDIs") for investment and
efficient portfolio management purposes, where applicable.
Investors should note that the Sub-Fund may invest principally
in FDI. This may expose the Fund to particular risks involving FDI.
The risks attached to investments in FDIs are set out in the
Prospectus under the section headed "Risk Factors".
You should inform yourself as to (a) the possible tax
consequences, (b) the legal and regulatory requirements, (c) any
foreign exchange restrictions or exchange control requirements and
(d) any other requisite governmental or other consents or
formalities which you might encounter under the laws of the country
of your citizenship, residence or domicile and which might be
relevant to your purchase, holding or disposal of the Shares.
Nomura NEXT FUNDS Ireland plc
An umbrella fund with segregated liability between the
sub-funds
Dated 30 March 2015[ ] 2016
IMPORTANT INFORMATION
Suitability of Investment
The Shares are not principal protected. The value of the Shares
may go up or down and you may not get back the amount you have
invested. See the section headed "Risk Factors" of the Prospectus
for a discussion of certain risks that should be considered by
you.
An investment in the Shares is only suitable for you if you
(either alone or with the help of an appropriate financial or other
advisor) are able to assess the merits and risks of such an
investment and have sufficient resources to be able to bear any
losses that may result from such an investment. The contents of
this document are not intended to contain and should not be
regarded as containing advice relating to legal, taxation,
investment or any other matters.
Profile of a Typical Investor
The Fund is suitable for investors seeking capital appreciation
and who are prepared to accept a high level of volatility.
Investment in the Fund should be viewed as a medium to long term
investment.
Responsibility
The Directors (whose names appear under the heading "Directors
of the Company" of the Prospectus) accept responsibility for the
information contained in the Prospectus and this Supplement. To the
best of the knowledge and belief of the Directors (who have taken
all reasonable care to ensure that such is the case) the
information contained in this Supplement when read together with
the Prospectus (as complemented, modified or supplemented by this
Supplement) is in accordance with the facts as at the date of this
Supplement and does not omit anything likely to affect the import
of such information.
General
This Supplement sets out information in relation to the Shares
and the Fund. You must also refer to the Prospectus which is
separate to this document and describes the Company and provides
general information about offers of shares in the Company. You
should not take any action in respect of the Shares unless you have
received a copy of the Prospectus. Should there be any
inconsistency between the contents of the Prospectus and this
Supplement, the contents of this Supplement will, to the extent of
any such inconsistency, prevail. This Supplement and the Prospectus
should both be carefully read in their entirety before any
investment decision with respect to Shares is made.
As of the date of this Supplement, the Company does not have any
loan capital (including term loans) outstanding or created but
unissued and no outstanding mortgages, charges or other borrowings
or indebtedness in the nature of borrowings, including bank
overdrafts and liabilities under acceptances or acceptance credits,
hire purchase or finance lease commitments, guarantees or other
contingent liabilities.
January 26, 2016 12:38 ET (17:38 GMT)
Description of Share Classes
Classes of Launch date Minimum Subscription Minimum Redemption Minimum ISIN Accumulation
Share Amount Amount Holdings or Income
------------- ------------- --------------------- --------------------- ------------ ------------- -------------
USD 13 March 30,000 Shares (or 30,000 Shares (or The cash IE00BVVSZ379 Accumulation
2015 cash equivalent) cash equivalent) equivalent
of 1 Share
------------- ------------- --------------------- --------------------- ------------ ------------- -------------
Intra-Day Portfolio Value ("iNAV")
Further information on intra-day portfolio value is contained in
the main body of the Prospectus under the heading "Intra-Day
Portfolio Value".
Fees and Expenses
The following table describes the fees and expenses you may pay
if you buy and hold Shares and will not be incurred by the Company
on behalf the Fund, and accordingly will not affect the Net Asset
Value of the relevant Share Class of the Fund.
Shareholder Fees Fees / Percentage
(fees paid directly from your investment)
------------------------------------------- ----------------------------------------------------
TER per Share Class Up to 0.45% per annum
------------------------------------------- ----------------------------------------------------
Subscription Charge Up to 5% of the Net Asset Value per Share
------------------------------------------- ----------------------------------------------------
Redemption Charge Up to 3% of the Net Asset Value per Share
------------------------------------------- ----------------------------------------------------
Switching Charge Up to 3% of the net asset value of Shares exchanged
------------------------------------------- ----------------------------------------------------
The TER is payable to the Investment Manager, and the Investment
Manager is then responsible for the payment of all other
operational expenses of the Fund.
The Promoter shall discharge the fees associated with the
establishment and approval of the Fund.
This section headed "Fees and Expenses" should be read in
conjunction with the sections headed "Fees and Expenses" and "Issue
and Repurchase Price/Calculation of Net Asset Value/Valuation of
Assets" in the Prospectus.
Risk Factors
Investors should refer to the Prospectus under the heading "Risk
Factors" for disclosure of risks.
Disruption Events
Investors should refer to the information contained in the
"Disruption Events" section in the main body of the Prospectus.
Miscellaneous
The Company has three additional sub-funds.
1 Nomura Nikkei 225 EUR-Hedged UCITS ETF.
2 Nomura Nikkei 225 USD-Hedged UCITS ETF.
3 Nomura JPX-Nikkei 400 Net Total Return Daily EUR Hedged Index UCITS ETF
The JPX-Nikkei 400 Net Total Return Daily USD Hedged Index
(hereinafter referred to as the "Index") and the "JPX-Nikkei 400
Total Return Index" are copyrighted materials compiled and
published by Japan Exchange Group, Inc. and Tokyo Stock Exchange,
Inc. (hereinafter collectively referred to as the "JPX Group") and
Nikkei Inc. (hereinafter referred to as "Nikkei"), and the JPX
Group and Nikkei jointly own the copyrights and other intellectual
property rights subsisting in the Index and the "JPX-Nikkei 400
Total Return Index" themselves and the methodologies used to
calculate the Index and "JPX-Nikkei 400 Total Return Index".
Ownership of trademarks and any other intellectual property rights
with respect to the marks to indicate the Index and the "JPX-Nikkei
400 Total Return Index" belong to the JPX Group and Nikkei;
The Fund is managed and sold exclusively at the risk of the
Investment Manager and the Distributor respectively, and the JPX
Group and Nikkei does not guarantee the Fund and shall assume no
obligation or responsibility with respect to the Fund.
The JPX Group and Nikkei shall not be obligated to continuously
publish the Index and "JPX-Nikkei 400 Total Return Index" and shall
not be liable for any errors, delays or suspensions of the
publication of the Index and "JPX-Nikkei 400 Total Return
Index".
The JPX Group and Nikkei shall have the right to change the
composition of the stocks included in the Index and "JPX-Nikkei 400
Total Return Index," the calculation methodology of the Index and
the "JPX-Nikkei 400 Total Return Index" or any other details of the
Index and "JPX-Nikkei 400 Total Return Index" and shall have the
right to discontinue the publication of the Index and "JPX-Nikkei
400 Total Return Index".
The Index is the exclusive property of JPX Group and Nikkei,
which has contracted with S&P Opco, LLC (a subsidiary of
S&P Dow Jones Indices LLC) ("S&P Dow Jones Indices") to
calculate and maintain the Index. S&P(R) is a registered
trademark of Standard & Poor's Financial Services LLC ("SPFS");
Dow Jones(R) is a registered trademark of Dow Jones Trademark
Holdings LLC ("Dow Jones"); and these trademarks have been licensed
to S&P Dow Jones Indices. "Calculated by S&P Dow Jones
Indices" and its related stylized mark(s) have been licensed for
use by the JPX Group and Nikkei.
The Fund is not sponsored, endorsed, sold or promoted by S&P
Dow Jones Indices, SPFS, Dow Jones or any of their affiliates
(collectively, "S&P Dow Jones Indices Entities"). S&P Dow
Jones Indices Entities do not make any representation or warranty,
express or implied, to the shareholders of the Fund or any member
of the public regarding the advisability of investing in securities
generally or in the Fund particularly or the ability of the Fund to
track general market performance. S&P Dow Jones Indices
Entities only relationship to the JPX Group and Nikkei with respect
to the Fund is the licensing of certain trademarks, service marks
and trade names of S&P Dow Jones Indices Entities and for the
providing of calculation and maintenance services related to the
Index. S&P Dow Jones Indices Entities are not responsible for
and have not participated in the determination of the prices and
amount of the Fund or the timing of the issuance or sale of the
Fund or in the determination or calculation of the equation by
which the Fund is to be converted into cash. S&P Dow Jones
Indices Entities have no obligation or liability in connection with
the administration, marketing or trading of the Fund. S&P Dow
Jones Indices LLC is not an investment advisor. Inclusion of a
security within the Index is not a recommendation by S&P Dow
Jones Indices Entities to buy, sell, or hold such security, nor is
it considered to be investment advice.
S&P DOW JONES INDICES ENTITIES DO NOT GUARANTEE THE
ADEQUACY, ACCURACY, TIMELINESS AND/OR THE COMPLETENESS OF THE INDEX
OR ANY DATA RELATED THERETO OR ANY COMMUNICATION, INCLUDING BUT NOT
LIMITED TO, ORAL OR WRITTEN COMMUNICATION (INCLUDING ELECTRONIC
COMMUNICATIONS) WITH RESPECT THERETO. S&P DOW JONES INDICES
ENTITIES SHALL NOT BE SUBJECT TO ANY DAMAGES OR LIABILITY FOR ANY
ERRORS, OMISSIONS, OR DELAYS THEREIN. S&P DOW JONES INDICES
ENTITIES MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY
DISCLAIMS ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A
PARTICULAR PURPOSE OR USE OR AS TO RESULTS TO BE OBTAINED BY THE
JPX GROUP AND NIKKEI INC., OWNERS OF THE INDEX OR ANY OTHER PERSON
OR ENTITY FROM THE USE OF THE INDEX OR WITH RESPECT TO ANY DATA
RELATED THERETO. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT
WHATSOEVER SHALL S&P DOW JONES INDICES ENTITIES BE LIABLE FOR
ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL
DAMAGES INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS, TRADING
LOSSES, LOST TIME OR GOODWILL, EVEN IF THEY HAVE BEEN ADVISED OF
THE POSSIBLITY OF SUCH DAMAGES, WHETHER IN CONTRACT, TORT, STRICT
LIABILITY, OR OTHERWISE."
This information is provided by RNS
The company news service from the London Stock Exchange
END
CIRBRGDBDXDBGLL
(END) Dow Jones Newswires
January 26, 2016 12:38 ET (17:38 GMT)
Nom Nk225 Eur (LSE:NXKE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nom Nk225 Eur (LSE:NXKE)
Historical Stock Chart
From Jul 2023 to Jul 2024
